The role of Hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic stroke

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Liu, Li Bin ^a,b   Li, Mu ^a   Zhuo, Wen Yan ^b   Zhang, Yu Sheng ^a   Xu, An Ding ^a  

^a JINAN UNIVERSITY   (China)

^b ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN EMBOLISM; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCLUSIVE CEREBROVASCULAR DISEASE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BLOOD; COMPLICATION; STROKE;

AGED; BIOMARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE; STROKE;

EID: 84922896561     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118301     Document Type: Article

References (28)

1. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1): 35-41. PMID: 7678184
2. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH, et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation. 2003; 108(2): 166-170. PMID: 12821545
3. Eikelboom JW, Hankey GJ, Baker RI, McQuillan A, Thom J, Staton J, et al. C-reactive protein in ischemic stroke and its etiologic subtypes. J Stroke Cerebrovasc Dis. 2003; 12(2): 74-81. PMID: 17903908
4. Pandey A, Shrivastava AK, Saxena K. Neuron specific enolase and c-reactive protein levels in stroke and its subtypes: correlation with degree of disability. Neurochem Res. 2014; 39(8): 1426-1432. doi: 10.1007/s11064-014-1328-9 PMID: 24838548
5. Luo Y, Wang Z, Li J, Xu Y. Serum CRP concentrations and severity of ischemic stroke subtypes. Can J Neurol Sci. 2012; 39(1): 69-73. PMID: 22384498
6. Terruzzi A, Valente L, Mariani R, Moschini L, Camerlingo M. C-reactive protein and aetiological subtypes of cerebral infarction. Neurol Sci. 2008; 29(4): 245-249. doi: 10.1007/s10072-008-0975-5 PMID: 18810599
7. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P, et al. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke. 2006; 37(8): 2018-2023. PMID: 16809555
8. Habib SS, Masri A AAI. Relationship of high sensitivity C-reactive protein with presence and severity of coronary artery disease. Pak J Med Sci. 2013; 29(6): 1425-1429. PMID: 24550967
9. Anderson JL, Allen Maycock CA, Lappe DL, Crandall BG, Horne BD, Bair TL, et al. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol. 2004; 94(10): 1255-1259. PMID: 15541240
10. Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004; 35(7): 1619-1624. PMID: 15155967
11. Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke. 2007; 38(6): 1774-1779. PMID: 17446427
12. Kara H, Akinci M, Degirmenci S, Bayir A, Ak A, Nayman A, et al. High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke. Neuropsychiatr Dis Treat. 2014; 10: 1451-1457. doi: 10.2147/NDT.S67665 PMID: 25125979
13. Beer C, Blacker D, Hankey GJ, Puddey IB. Association of clinical and aetiologic subtype of acute ischaemic stroke with inflammation, oxidative stress and vascular function: a cross-sectional observational study. Med Sci Monit. 2011; 17(9): CR467-473. PMID: 21873941
14. Marder VJ, Francis CW. Plasmin degradation of cross-linked fibrin. Ann N Y Acad Sci. 1983; 408: 397-406. PMID: 6223558
15. Tombul T, Atbas C, Anlar O. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. J Clin Neurosci. 2005; 12(4): 429-434. PMID: 15925775
16. Matsumoto M, Sakaguchi M, Okazaki S, Furukado S, Tagaya M, Etani H, et al. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation. Cerebrovasc Dis. 2013; 35(1): 64-72. doi: 10.1159/000345336 PMID: 23428999
17. Ageno W, Finazzi S, Steidl L, Biotti MG, Mera V, Melzi D'Eril G, et al. Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med. 2002; 162(22): 2589-2593. PMID: 12456231
18. Koch HJ, Horn M, Bogdahn U, Ickenstein GW. The relationship between plasma D-dimer concentrations and acute ischemic stroke subtypes. J Stroke Cerebrovasc Dis. 2005; 14(2): 75-79. PMID: 17904004
19. Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke. 2008; 39(8): 2280-2287. doi: 10.1161/STROKEAHA.107.505354 PMID: 18535284
20. Isenegger J, Meier N, Lämmle B, Alberio L, Fischer U, Nedeltchev K, et al. D-dimers predict stroke subtype when assessed early. Cerebrovasc Dis. 2010; 29(1): 82-86. doi: 10.1159/000256652 PMID: 19907168
21. Zi WJ, Shuai J. Plasma D-dimer levels are associated with stroke subtypes and infarction volume in patients with acute ischemic stroke. PLoS One. 2014; 9(1): e86465. doi: 10.1371/journal.pone.0086465 PMID: 24466108
22. Turaj W, Słowik A, Pułyk R, Adamski M, Szczudlik A. Comparison of plasma concentrations of fibrinogen in patients with ischemic stroke due to large vessel disease and small vessel disease. Neurol Neurochir Pol. 2006; 40(4): 297-301. PMID: 16967351
23. Vibo R, Kõrv J, Roose M, Kampus P, Muda P, Zilmer K, et al. Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome. Free Radic Res. 2007; 41(3): 282-287. PMID: 17364956
24. Eidelman RS, Hennekens CH. Fibrinogen: a predictor of stroke and marker of atherosclerosis. Eur Heart J. 2003; 24(6): 499-500. PMID: 12643881
25. Siegerink B, Rosendaal FR, Algra A. Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost. 2009; 7(3): 385-390. doi: 10.1111/j.1538-7836.2008.03266.x PMID: 19143925
26. Chuang SY, Bai CH, Chen WH, Lien LM, Pan WH. Fibrinogen independently predicts the development of ischemic stroke in a Taiwanese population: CVDFACTS study. Stroke. 2009; 40(5): 1578-1584. doi: 10.1161/STROKEAHA.108.540492 PMID: 19286580
27. Giannopoulos S, Kosmidou M, Hatzitolios AI, Savopoulos CG, Ziakas A, Karamouzis M. Measurements of endothelin-1, C-reactive protein and fibrinogen plasma levels in patients with acute ischemic stroke. Neurol Res. 2008; 30(7): 727-730. doi: 10.1179/174313208X297904 PMID: 18489822
28. Carter AM, Catto AJ, Bamford JM, Grant PJ. Gender-specific associations of the fibrinogen Bβ448 polymorphism, fibrinogen levels, and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol. 1997; 17(3): 589-594. PMID: 9102181